189 related articles for article (PubMed ID: 35727472)
1. Silibinin ameliorates cisplatin-induced acute kidney injury via activating Nfe2l1-mediated antioxidative response to suppress the ROS/MAPK signaling pathway.
Yang F; Jia M; Deng C; Xiao B; Dai R; Xiang Y
J Mol Histol; 2022 Aug; 53(4):729-740. PubMed ID: 35727472
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-140-5p attenuated oxidative stress in Cisplatin induced acute kidney injury by activating Nrf2/ARE pathway through a Keap1-independent mechanism.
Liao W; Fu Z; Zou Y; Wen D; Ma H; Zhou F; Chen Y; Zhang M; Zhang W
Exp Cell Res; 2017 Nov; 360(2):292-302. PubMed ID: 28928081
[TBL] [Abstract][Full Text] [Related]
3. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury.
Yan W; Xu Y; Yuan Y; Tian L; Wang Q; Xie Y; Shao X; Zhang M; Ni Z; Mou S
Free Radic Res; 2017; 51(7-8):669-683. PubMed ID: 28750561
[TBL] [Abstract][Full Text] [Related]
4. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation.
Meng XM; Ren GL; Gao L; Yang Q; Li HD; Wu WF; Huang C; Zhang L; Lv XW; Li J
Lab Invest; 2018 Jan; 98(1):63-78. PubMed ID: 29106395
[TBL] [Abstract][Full Text] [Related]
5. Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis.
Chen X; Wei W; Li Y; Huang J; Ci X
Chem Biol Interact; 2019 Aug; 308():269-278. PubMed ID: 31153982
[TBL] [Abstract][Full Text] [Related]
6. The effect of monotropein on alleviating cisplatin-induced acute kidney injury by inhibiting oxidative damage, inflammation and apoptosis.
Zhang Y; Chen Y; Li B; Ding P; Jin D; Hou S; Cai X; Sheng X
Biomed Pharmacother; 2020 Sep; 129():110408. PubMed ID: 32574971
[TBL] [Abstract][Full Text] [Related]
7. Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling.
Huang YC; Tsai MS; Hsieh PC; Shih JH; Wang TS; Wang YC; Lin TH; Wang SH
Toxicol Appl Pharmacol; 2017 Aug; 329():128-139. PubMed ID: 28558962
[TBL] [Abstract][Full Text] [Related]
8. Anemoside B4 attenuates nephrotoxicity of cisplatin without reducing anti-tumor activity of cisplatin.
He L; Zhang Y; Kang N; Wang Y; Zhang Z; Zha Z; Yang S; Xu Q; Liu Y
Phytomedicine; 2019 Mar; 56():136-146. PubMed ID: 30668334
[TBL] [Abstract][Full Text] [Related]
9. Silibinin ameliorats H
Guo H; Wang Y; Liu D
Acta Histochem; 2020 Dec; 122(8):151620. PubMed ID: 33068964
[TBL] [Abstract][Full Text] [Related]
10. Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells.
Gou S; Qiu L; Yang Q; Li P; Zhou X; Sun Y; Zhou X; Zhao W; Zhai W; Li G; Wu Y; Ren Y; Qi Y; Zhang Y; Gao Y
Toxicol Appl Pharmacol; 2021 Jun; 420():115523. PubMed ID: 33838154
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline attenuates cisplatin-induced acute kidney injury through pleiotropic effects.
Nakagawa T; Kakizoe Y; Iwata Y; Miyasato Y; Mizumoto T; Adachi M; Izumi Y; Kuwabara T; Suenaga N; Narita Y; Jono H; Saito H; Kitamura K; Mukoyama M
Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1347-F1357. PubMed ID: 30043627
[TBL] [Abstract][Full Text] [Related]
12. Silibinin protects rat pancreatic β-cell through up-regulation of estrogen receptors' signaling against amylin- or Aβ
Yang J; Sun Y; Xu F; Liu W; Hayashi T; Hattori S; Ushiki-Kaku Y; Onodera S; Tashiro SI; Ikejima T
Phytother Res; 2019 Apr; 33(4):998-1009. PubMed ID: 30729588
[TBL] [Abstract][Full Text] [Related]
13. Feedback regulation of antioxidant transcription factor NFE2L1 and immunostimulatory factor 41BBL mediates the crosstalk between oxidative stress and tumor immunity.
Qiu L; Ning H; Zhu Y; Yang Q; Liu L; Luo L; Gao Y; Xing Y
Mol Immunol; 2022 Jan; 141():265-272. PubMed ID: 34902807
[TBL] [Abstract][Full Text] [Related]
14. Activation of TFEB-mediated autophagy by trehalose attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury.
Zhu L; Yuan Y; Yuan L; Li L; Liu F; Liu J; Chen Y; Lu Y; Cheng J
Theranostics; 2020; 10(13):5829-5844. PubMed ID: 32483422
[No Abstract] [Full Text] [Related]
15. Madecassoside ameliorates cisplatin-induced nephrotoxicity by inhibiting activation of the mitogen activated protein kinase pathway.
Yuan H; Zhao Y; Li S; Qin J; Yu X
Environ Toxicol; 2023 Jul; 38(7):1473-1483. PubMed ID: 37087747
[TBL] [Abstract][Full Text] [Related]
16. Baicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-κB Pathways.
Sahu BD; Mahesh Kumar J; Sistla R
PLoS One; 2015; 10(7):e0134139. PubMed ID: 26222683
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of long isoforms of Nfe2l1 sensitizes MIN6 pancreatic β cells to arsenite-induced cytotoxicity.
Cui Q; Fu J; Hu Y; Li Y; Yang B; Li L; Sun J; Chen C; Sun G; Xu Y; Zhang Q; Pi J
Toxicol Appl Pharmacol; 2017 Aug; 329():67-74. PubMed ID: 28549828
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect and underlying mechanism of Shenkang injection against cisplatin-induced acute kidney injury in mice.
Su J; He T; You J; Cao J; Wang Q; Cao S; Mei Q; Zeng J; Liu L
J Ethnopharmacol; 2023 Jan; 301():115805. PubMed ID: 36216195
[TBL] [Abstract][Full Text] [Related]
19. Protective role of silibinin against myocardial ischemia/reperfusion injury-induced cardiac dysfunction.
Chen YH; Lin H; Wang Q; Hou JW; Mao ZJ; Li YG
Int J Biol Sci; 2020; 16(11):1972-1988. PubMed ID: 32398964
[TBL] [Abstract][Full Text] [Related]
20. Galangin ameliorates cisplatin induced nephrotoxicity in vivo by modulation of oxidative stress, apoptosis and inflammation through interplay of MAPK signaling cascade.
Tomar A; Vasisth S; Khan SI; Malik S; Nag TC; Arya DS; Bhatia J
Phytomedicine; 2017 Oct; 34():154-161. PubMed ID: 28899498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
